Literature DB >> 578060

Secretin: high plasma levels in diabetes mellitus.

E R Trimble, K D Buchanan, D R Hadden, D A Montgomery.   

Abstract

Plasma immunoreactive secretin levels were measured in 22 newly diagnosed non-ketotic, maturity-onset diabetics and 10 healthy control subjects during 50 gram oral glucose tolerance test (OGTT). The test was repeated in the diabetic group after 6 months' dietary treatment. At diagnosis the fasting secretin levels in the diabetics were higher than in control subjects but fell within the normal range following dietary treatment. In the diabetics there was a significant positive correlation between the fasting glucose and fasting secretin levels at the time of diagnosis. Suppression of secretin levels occurred during the OGTT, both in diabetic and control subjects.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 578060     DOI: 10.1530/acta.0.0850799

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  3 in total

1.  Effects of secretin on glycogenolysis in cultured liver cells.

Authors:  M Matsumura; H Akiyoshi
Journal:  Gastroenterol Jpn       Date:  1980

2.  Effect of endogenous secretin on plasma glucagon after total pancreatectomy.

Authors:  T Sudo; T Suzuki; T Tobe; H Umemura; S Shiraha; T Kuyama
Journal:  World J Surg       Date:  1981-11       Impact factor: 3.352

3.  Impairment of hormone-stimulated cardiac adenylate cyclase activity in the genetically obese (fa/fa) Zucker rat.

Authors:  P Chatelain; P Robberecht; P De Neef; J C Camus; P Poloczek; J Christophe
Journal:  Pflugers Arch       Date:  1981-04       Impact factor: 3.657

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.